In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.

 
Web www.patentalert.com

< Molecular cardiotoxicology modeling

> Carrier of a diamond fine particle for immobilizing virus

~ 00468